New Paragraph IV Certifications as of March 27, 2018
DRUG NAME DOSAGE FORM STRENGTH RLD DATE OF SUBMISSION Halobetasol Propionate New Lotion 0.05% Ultavate, 208183 1/24/2018 Pregabal...
Conflict Between IP Courts Of Milan And Rome: "Torpedo Action" Is Back (Maybe)
The deprecated slowness of the Italian Courts has caused the phenomenon of the so-called “Italian Torpedo Actions” (1) , in litigation ha...
Belgium SPC Calculation
In view of the CJEU Seattle Genetics ( C - 471/14 ) and Incyte ( C - 492/16 ) the Belgian Office for Intellectual Property recently issued...
First in Vitro Diagnostic Blood Test for the evaluation of mTBI
Basic Information: On February 14, 2018 , The U.S. Food and Drug Administration (US FDA) permitted marketing of the first blood test ...
France SPC Calculation
The French Intellectual Property Office previously did not accepted to adjust the expiration date of a granted Supplementary Protection Ce...
Week 12 (19th Mar, 2018 to 25th Mar, 2018): IPRs Report
AIA Review Filing Date Petitioner Respondent App Respondent Patent Tech Center IPR2018-00783 3/19/2018 Amperex Technology Ltd. 11997948 ...
Week 11 (12th Mar, 2018 to 18th Mar, 2018): IPRs Report
AIA Review Filing Date Petitioner Respondent App Respondent Patent Tech Center IPR2018-00768 3/12/2018 Taylor Made Golf Company, Inc. 14...
New Paragraph IV Certifications as of March 13, 2018
DRUG NAME DOSAGE FORM STRENGTH RLD DATE OF SUBMISSION Dapagliflozin Tablets 5 mg and 10 mg Farxiga, 202293 1/8/2018 Metformin Hydro...
Week 10 (05th Mar, 2018 to 11th Mar, 2018): IPRs Report
AIA Review Filing Date Petitioner Respondent App Respondent Patent Tech Center IPR2018-00686 3/5/2018 Nikon Corporation 14147021 9728574...
New Paragraph IV Certifications as of February 28, 2018
DRUG NAME DOSAGE FORM STRENGTH RLD DATE OF SUBMISSION Dapagliflozin and Saxagliptan Tablets 10 mg/5 mg Qtern, 209091 1/8/2018 Ib...
Week 09 (26th Feb, 2018 to 04th Mar, 2018): IPRs Report
AIA Review Filing Date Petitioner Respondent App Respondent Patent Tech Center IPR2018-00687 2/26/2018 Nikon Corporation 9305756 6731335...
US4441222: Automatic Bed Maker
Sick of making the bed every day? Well, with this absurd invention, you wouldn't need to. (Click here to view the Patent) You can u...
Cyclosporine - USA
Product: RESTASIS ® (Cyclosporine Ophthalmic Emulsion) 0.05% Innovator: Allergan Generic Filer: Mylan Patents : US8629111 , US8...
Subscribe to:
Posts
(
Atom
)
Top Five Things CEOs of Startups Should Do for Intellectual Property Protection to See Enormous Growth
Intellectual Property (IP) protection is a crucial yet often overlooked aspect of running a successful startup. A solid IP strategy can help...
